PriceTargets.com logo

Kits Eyecare - KTYCF Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $5.25
  • Forecasted Upside: 71.01%
  • Number of Analysts: 1
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$3.07 As of 03/24/2023 01:00 AM ET
+0 (0.00%)

This chart shows the closing price for KTYCF by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Kits Eyecare Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for KTYCF and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for KTYCF

Analyst Price Target is $5.25
▲ +71.01% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for Kits Eyecare in the last 3 months. The average price target is $5.25, with a high forecast of $7.00 and a low forecast of $3.50. The average price target represents a 71.01% upside from the last price of $3.07.

This chart shows the closing price for KTYCF for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 1 contributing investment analysts is to buy stock in Kits Eyecare.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/2/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/31/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/31/2022
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/29/2022
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/27/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/26/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
2/24/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/26/2023

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
8/12/2022ScotiabankLower TargetC$5.00 ➝ C$3.50
5/12/2022Canaccord Genuity GroupLower TargetBuy ➝ BuyC$8.00 ➝ C$7.00
11/17/2021ScotiabankLower TargetOutperformC$7.50 ➝ C$5.00
8/13/2021ScotiabankLower TargetOutperformC$10.50 ➝ C$7.50
6/30/2021ScotiabankInitiated CoverageOutperform
(Data available from 3/26/2018 forward)

News Sentiment Rating

0.25 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 1 very positive mentions
  • 1 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
8/28/2022
  • 0 very positive mentions
  • 1 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
9/27/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/27/2022
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/26/2022
  • 1 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/26/2022
  • 2 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/25/2023
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/24/2023
  • 1 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/26/2023

Current Sentiment

  • 1 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

Kits Eyecare logo
Kits Eyecare Ltd. operates a digital eyecare platform for eyes in the United States and Canada. The company manufactures progressive and contact lenses, eyeglasses, and frames under the KITS brand, as well as distributes eyewear products of various brands. It operates through a network of optical e-commerce websites, including KITS.com, KITS.ca, OptiContacts.com, and ContactsExpress.ca. The company was incorporated in 2018 and is headquartered in Vancouver, Canada.
Read More

Today's Range

Now: $3.07
Low: $3.07
High: $3.07

50 Day Range

MA: $2.75
Low: $2.43
High: $3.16

52 Week Range

Now: $3.07
Low: $1.44
High: $3.16

Volume

N/A

Average Volume

1,119 shs

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Kits Eyecare?

The following Wall Street sell-side analysts have issued reports on Kits Eyecare in the last year: Canaccord Genuity Group Inc., and Scotiabank.
View the latest analyst ratings for KTYCF.

What is the current price target for Kits Eyecare?

2 Wall Street analysts have set twelve-month price targets for Kits Eyecare in the last year. Their average twelve-month price target is $5.25, suggesting a possible upside of 71.0%. Canaccord Genuity Group Inc. has the highest price target set, predicting KTYCF will reach $7.00 in the next twelve months. Scotiabank has the lowest price target set, forecasting a price of $3.50 for Kits Eyecare in the next year.
View the latest price targets for KTYCF.

What is the current consensus analyst rating for Kits Eyecare?

Kits Eyecare currently has 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe KTYCF will outperform the market and that investors should add to their positions of Kits Eyecare.
View the latest ratings for KTYCF.

What other companies compete with Kits Eyecare?

Other companies that are similar to Kits Eyecare include Allegro.eu, CBD of Denver, Deliveroo, Emerge Commerce and home24. Learn More about companies similar to Kits Eyecare.